Breaking Finance News

Zacks Investment Research reported on Chart Industries, Inc. (NASDAQ:GTLS), upping its stock price target to $37.00 earlier today

Just yesterday Chart Industries, Inc. (NASDAQ:GTLS) traded -0.72% lower at $33.20. Chart Industries, Inc.’s 50-day moving average is $31.34 and its 200-day moving average is $26.94. The last closing price is up 22.33% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 12,777 shares of GTLS traded hands, down from an average trading volume of 322,765

Zacks Investment Research raised the target price of Chart Industries, Inc. (NASDAQ:GTLS) to $37.00 stating a potential upside of 0.11%.

Previously on Tuesday October 11, 2016, Gabelli reported on Chart Industries, Inc. (NASDAQ:GTLS) increased the target price from $0.00 to $51.00. At the time, this indicated a possible upside of 0.54%.

Recent Performance Chart

Chart Industries, Inc. (NASDAQ:GTLS)

Chart Industries, Inc. has 52 week low of $13.27 and a 52 week high of $34.06 and has a market capitalization of $0.

Also covering Chart Industries, Inc.'s target, a total of 13 equity analysts have released a report on Chart Industries, Inc.. The 12-month price target is $25.00 with three brokers rating the stock a strong buy, 3 firms rating the stock a buy, 8 equity analysts rating the company a hold, 0 brokerages rating the company a underperform, and lastly 0 brokers rating the stock a sell.

Brief Synopsis On Chart Industries, Inc. (NASDAQ:GTLS)

Chart Industries, Inc. (Chart) is a diversified manufacturer of engineered equipment for the industrial gas, energy, and biomedical industries. The Company's equipment and engineered systems are used for low-temperature and cryogenic applications. It operates through three segments, including Energy & Chemicals (E&C), Distribution & Storage (D&S), and BioMedical. The Company's products include vacuum insulated containment vessels, heat exchangers, cold boxes, other cryogenic components and equipment for respiratory therapy. The Company's E&C and D&S segment's manufacture products used primarily in energy-related and industrial applications, such as the separation, liquefaction, distribution and storage of hydrocarbon and industrial gases. The Company, through its BioMedical segment, supplies cryogenic and other equipment used in respiratory healthcare and life sciences, including biological research and animal breeding.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *